GlucoTrack, Inc.
GCTK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 5.00 | -0.00 | -0.00 | -0.19 |
| FCF Yield | 0.00% | -126.19% | -75.71% | -2.37% |
| EV / EBITDA | 0.00 | 1.32 | 0.72 | -12.60 |
| Quality | ||||
| ROIC | 0.00% | -67.06% | -45.45% | -538.40% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 50.00% |
| Cash Conversion Ratio | 0.79 | 0.43 | 0.35 | 0.81 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 0.00% | -27.00% | 15.75% | 16.19% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 1.94 | 1.29 | 0.47 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -21,632.73 | -18,135.00 | -7,440.00 |